You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
For in vitro diagnostic use. Others Elecsys beta-CrossLaps serum IVD Elecsys® β-CrossLaps/serum CPS_000446 09 005 781 190 9 005 781 190 09005781190 9005781190 09005781190 B-CrossLaps/serum Elecsys E2G 100 V2 Elecsys beta-CrossLaps/serum 07613336171561 Reagents, kits 100 tests cobas e 402/801 true 09 005 773 190 9 005 773 190 09005773190 9005773190 09005773190 B-CrossLaps/serum Elecsys cobas e 100 V2 Elecsys beta-CrossLaps/serum 07613336171554 Reagents, kits 100 tests cobas e 411/601/602 true 09005781500 Elecsys β-CrossLaps/serum en 2 FF000000059F970E FF000000048BDC0E 09005781190 09005781214 9494 cobas e 402 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of degradation products of type I collagen in human serum and plasma as an aid in assessing bone resorption. The test may be used as an aid in monitoring antiresorptive therapies in osteoporotic patients.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09005773500 Elecsys β-CrossLaps/serum en 1 FF000000048BD90E FF000000048BD90E 09005773190 2325 cobas e 602 619 cobas e 601 618 cobas e 411 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of degradation products of type I collagen in human serum and plasma as an aid in assessing bone resorption. The test may be used as an aid in monitoring antiresorptive therapies in osteoporotic patients.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en